Article info
Basic and translational research
Concise report
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
- Correspondence to Dr Theo Rispens, Sanquin Blood Supply, Plesmanlaan 125, Amsterdam 1066 CX, The Netherlands; T.rispens{at}sanquin.nl
Citation
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
Publication history
- Received July 8, 2014
- Revised September 15, 2014
- Accepted October 5, 2014
- First published October 23, 2014.
Online issue publication
October 31, 2019
Article Versions
- Previous version (2 July 2019).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions